{"id":"W3027487087","doi":"10.1111/liv.14535","title":"Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies","year":2020,"lang":"en","type":"article","venue":"Liver International","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Toronto General Hospital; University of Calgary","funders":"AbbVie","keywords":"Internal medicine; Medicine; Regimen; Discontinuation; Adverse effect; Cirrhosis; Gastroenterology; Hepatitis C virus; Population; Hepatitis C; Sofosbuvir; Clinical endpoint; Clinical trial; Immunology; Ribavirin; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02229713,0.001044989,0.002947026,0.001553073,0.0003334679,0.001756895,0.0006144473,0.0008645477,0.001323031],"category_scores_gemma":[0.01032387,0.0005278934,0.006604594,0.001611303,0.0005795029,0.001077051,0.0006872676,0.001189218,0.0002004921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001000254,"about_ca_system_score_gemma":0.001386636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004160493,"about_ca_topic_score_gemma":0.001109415,"domain_scores_codex":[0.9920377,0.005571796,0.0006563179,0.0005102436,0.0008815567,0.0003423925],"domain_scores_gemma":[0.9900362,0.004188966,0.003444239,0.0005796267,0.001044787,0.0007061278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.4444788,0.003634379,0.2105389,0.0065697,0.1175911,0.0002060452,0.0005524044,0.003446606,0.01323041,0.0002039926,0.001136506,0.1984112],"study_design_scores_gemma":[0.1242089,0.1611219,0.5642757,0.001430781,0.1340532,0.0008699097,0.0003279531,0.0039313,0.004827304,0.0004413043,0.004286354,0.0002252406],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9331322,0.06134414,0.001460233,0.0003185878,0.00005898507,0.001294881,0.001106985,0.00006353014,0.001220497],"genre_scores_gemma":[0.9911378,0.00579669,0.0009774693,0.0002870187,0.00009419642,0.0003305236,0.001227067,0.00001909341,0.0001301519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02229713,"threshold_uncertainty_score":0.1179199,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05431274095498577,"score_gpt":0.3701337365390762,"score_spread":0.3158209955840904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}